Geode Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4M | Buy |
|
|||||
|
2025
Q1 | $20.5M | Buy |
|
|||||
|
2024
Q4 | $29.9M | Buy |
|
|||||
|
2024
Q3 | $32.5M | Buy |
|
|||||
|
2024
Q2 | $27.6M | Buy |
|
|||||
|
2024
Q1 | $16.2M | Buy |
|
|||||
|
2023
Q4 | $11.2M | Buy |
|
|||||
|
2023
Q3 | $8.22M | Buy |
|
|||||
|
2023
Q2 | $9.77M | Buy |
|
|||||
|
2023
Q1 | $8.26M | Buy |
|
|||||
|
2022
Q4 | $9.82M | Buy |
|
|||||
|
2022
Q3 | $10.6M | Buy |
|
|||||
|
2022
Q2 | $9.8M | Buy |
|
|||||
|
2022
Q1 | $9.14M | Buy |
|
|||||
|
2021
Q4 | $18M | Sell |
|
|||||
|
2021
Q3 | $18.9M | Buy |
|
|||||
|
2021
Q2 | $10.5M | Buy |
|
|||||
|
2021
Q1 | $10.1M | Buy |
|
|||||
|
2020
Q4 | $6.55M | Buy |
|
|||||
|
2020
Q3 | $6.42M | Buy |
|